introduction of sysmex
play

Introduction of Sysmex Sysmex Partec GmbH President & CEO - PowerPoint PPT Presentation

Introduction of Sysmex Sysmex Partec GmbH President & CEO Shinjiro Akamatsu Sysmex Group Overview Outline Head Office Chuo-ku, Kobe, Japan Established February 20, 1968 Paid-in Capital JPY12,276 million Consolidated Sales JPY


  1. Introduction of Sysmex Sysmex Partec GmbH President & CEO Shinjiro Akamatsu

  2. Sysmex Group Overview

  3. Outline Head Office Chuo-ku, Kobe, Japan Established February 20, 1968 Paid-in Capital JPY12,276 million Consolidated Sales JPY 281,935 million Subsidiaries and Affiliates 74 (Japan: 11 Overseas: 63) 8,445 (Japan: 3,517 Overseas: 4,928) Number of Employees *including part-time employees Development, manufacture, sales, import and export of diagnostics Main Lines of Business testing instruments and reagents, and related software SYS tematical ME dics + X Corporate name mean As of the end of March 2018 3

  4. History FY1995 FY2017 Overseas affiliates: 5 63 Product exports: 90 countries Over 190 countries Overseas sales ratio: Approx. 45% 84.0% Overseas employees: Approx. 250 (20%) 4,928 (58.4%) (100 million yen) 2013: Partnership w/Partec GmbH 3,000 9,000 2008: Established Technopark 1968: Established as a sales company 8,000 for TOA ELECTRIC (presently TOA) 2007: Established the “Sysmex Way” 2,500 7,000 1998: Company name change, and head office relocation 2,000 6,000 Global alliance 1995: Siemens / 1998: Roche 5,000 1995: Sysmex Deutschland for direct sales 1,500 4,000 1991: Sysmex UK for direct sales 1,000 3,000 1980: Sysmex Europe for customer support 2,000 1978: Launched the corporate brand name “Sysmex” 500 1,000 0 0 1968 1972 1976 1980 1984 1988 1992 1996 2000 2004 2008 2012 2016 Overseas sales Japan sales Number of Employees 4

  5. Business Segments Sales ratio by business Production Business Instruments Reagents ● Others ● Hematology ● ● Hematology ● Life Science 6.3% 3.2% ● ● Urinalysis ● ● ● Hemostasis Immunochemistry 62.0% 16.0% ○ ● Net Sales Clinical Chemistry \ 281.9 billion ● ○ Hemostasis ● Imm./ 5.2% 2018.3 F.Y. Chem. ● ● Life Science 7.3% ● ● ● Urinalysis Others ●: Own brand ○: Including other brands Instruments Reagents Maintenance service 5

  6. Positioning In Vitro Diagnostics *Sysmex estimate as of March 2016 1st: Sysmex Market Share 1st : Roche (Switz.) 2nd: Danaher (USA) 2nd : Danaher (USA) Hematology (Beckman Coulter) 3rd : Siemens (Germany) 3rd: Siemens (Germany) Hema- ・ tology Immuno- ・ chemisry ・ ・ Sysmex Others Urinalysis 7th: Sysmex (Urine sediment) 1st: Sysmex 2nd: Danaher (USA) *Sysmex estimate as of May 2018 Clinical *Sysmex estimates as of May 2018 (Iris) Chemistry 1st: Sysmex + Siemens (Germany) Hemostasis 2nd: IL (Spain) 3rd: Stago (France) Ranked in global top 10 as the only Asian based company 6

  7. Network (Global)  Export to more than 190 countries Sales ratio by region  63 overseas affiliates  84.0% of sales made in overseas markets AP Japan 8.8% *As of the end of March 2018 16.0% Sysmex Corporation (日本) China 25.6% 2018.3 F.Y. Americas 23.5% EMEA 26.2% Sysmex Shanghai Ltd. Sysmex Europe GmbH Sysmex Asia Pacific Pte Ltd. Sysmex America, Inc. 7

  8. Production Bases  Instruments production base: 4 base in Japan & 1 in Germany  Reagents production bases: 2 bases in Japan, 8 bases in overseas Germany Japan USA China Brazil India Singapore 8

  9. Strategy together with Partec GmbH

  10. Introduction of Sysmex Partec GmbH (SPG)

  11. Overview  Established in 1967  Joined Sysmex group in September, 2013  Headquarters: Görlitz, Germany  4 facilities in Germany (2 in Görlitz, 1 in Münster, 1 in Leipzig)  Headcount: 175 *as of July 2018  Certification: ISO9001:2015, ISO13485:2016 CE-IVD for IVD products, CE mark for non-IVD products WHO-Prequalification for CD4 solutions 11

  12. Facilities ( ): Head count # Flugplatz (13) Münster (21) Leipzig (7) Arndtstrasse (134) Görlitz (147) - 4 facilities in Germany - Münster: Customer facing function - Saxon area: Back office 12

  13. SPG Products Overview EHC (Essential Health Care) Reagents CyFlow Counter R&I-FCM (Research & Industrial FCM) CyFlow Space CyFlow Cube8 13 CyFlow PA Reagents & Consumables CyFlow Cube 6

  14. Advantages of SPG Development Optics technology Connection with researchers especially in EU region Support / funding by public organization Bio-cluster network in Saxon Production Precision machining and assembly by Meister Easy access to suppliers by good location at the middle of west and east Europe Support / funding by public organization 14

Recommend


More recommend